These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19028345)

  • 1. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.
    Eisbruch A; Gregoire V
    Semin Radiat Oncol; 2009 Jan; 19(1):43-52. PubMed ID: 19028345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation.
    Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.
    Vorwerk H; Hess CF
    Radiat Oncol; 2011 Aug; 6():97. PubMed ID: 21854585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selection and delineation of lymph node target volumes in head and neck neoplasms].
    Grégoire V; Daisne JF; Bauvois C; Coche E; Duprez T; Hamoir M; Reychler H
    Cancer Radiother; 2001 Oct; 5(5):614-28. PubMed ID: 11715313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ system.
    Loo H; Fairfoul J; Chakrabarti A; Dean JC; Benson RJ; Jefferies SJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):40-7. PubMed ID: 20926268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.
    Grégoire V; Coche E; Cosnard G; Hamoir M; Reychler H
    Radiother Oncol; 2000 Aug; 56(2):135-50. PubMed ID: 10927132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
    Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition.
    Grégoire V; Daisne JF; Geets X; Levendag P
    Rays; 2003; 28(3):217-24. PubMed ID: 15018310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
    Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
    Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
    Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V
    Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.
    Eisbruch A; Foote RL; O'Sullivan B; Beitler JJ; Vikram B
    Semin Radiat Oncol; 2002 Jul; 12(3):238-49. PubMed ID: 12118389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the delineation of the gross tumor volume and clinical target volume for head and neck squamous cell carcinomas.
    Sanguineti G; Foppiano F; Marcenaro M; Roncallo F; Corvò R; Ameli F; Vitale V
    Tumori; 2001; 87(3):153-61. PubMed ID: 11504370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.
    Eisbruch A; Marsh LH; Martel MK; Ship JA; Ten Haken R; Pu AT; Fraass BA; Lichter AS
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):559-68. PubMed ID: 9635702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
    Braaksma M; Levendag P
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the target for radiotherapy of head and neck cancer.
    Nuyts S
    Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S50-5. PubMed ID: 17921086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Target-volume selection and delineation in the cervico-maxillo-facial region: beyond the concepts of the ICRU].
    Grégoire V
    Cancer Radiother; 2002 Nov; 6 Suppl 1():29s-31s. PubMed ID: 12587380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.